Raphael Oliver Koliopanos

Mr. Raphael Oliver Koliopanos

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 December 2022 in Scientific Reports
Verified
Journal Article
Open access
PDF file
RKRaphael Oliver Koliopanos
Raphael Oliver Koliopanos
ATAlexandre Thiéry
Alexandre Thiéry
DADomingo Aguilera-Garcia
Domingo Aguilera-Garcia
MZMartin Zoche
Martin Zoche
HMHolger Moch
Holger Moch
AZAndreas Ziegler
Andreas Ziegler
Rapid advances in high-throughput DNA sequencing technologies have enabled the conduct of whole genome sequencing (WGS) studies, and several bioinformatics pipelines have become available. The aim of this study was the comparison of 6 WGS data pre-processing pipelines, involving two mapping and alignment approaches (GATK utilizing BWA-MEM2 2.2.1, and DRAGEN 3.8.4) and three variant calling pipelines (GATK 4.2.4.1, DRAGEN 3.8.4 and DeepVariant 1.1.0). We sequenced one genome in a bottle (GIAB) sample 70 times in different runs, and one GIAB trio in triplicate. The truth set of the GIABs was used for comparison, and performance was assessed by computation time, F1 score, precision, and recall. In the mapping and alignment step, the DRAGEN pipeline was faster than the GATK with BWA-MEM2 pipeline. DRAGEN showed systematically higher F1 score, precision, and recall values than GATK for single nucleotide variations (SNVs) and Indels in simple-to-map, complex-to-map, coding and non-coding regions. In the variant calling step, DRAGEN was fastest. In terms of accuracy, DRAGEN and DeepVariant performed similarly and both superior to GATK, with slight advantages for DRAGEN for Indels and for DeepVariant for SNVs. The DRAGEN pipeline showed the lowest Mendelian inheritance error fraction for the GIAB trios. Mapping and alignment played a key role in variant calling of WGS, with the DRAGEN outperforming GATK.

11 July 2024 in Biometrical Journal
Verified
Journal Article
Open access
RKRaphael Oliver Koliopanos
Raphael Oliver Koliopanos
CRCristian Riccio
Cristian Riccio
DADomingo Aguilera‐Garcia
Domingo Aguilera‐Garcia
SBStefan Blankenberg
Stefan Blankenberg
LGLinlin Guo
Linlin Guo
AZAndreas Ziegler
Andreas Ziegler
Rapid advances in high‐throughput DNA sequencing technologies have enabled large‐scale whole genome sequencing (WGS) studies. Before performing association analysis between phenotypes and genotypes, preprocessing and quality control (QC) of the raw sequence data need to be performed. Because many biostatisticians have not been working with WGS data so far, we first sketch Illumina's short‐read sequencing technology. Second, we explain the general preprocessing pipeline for WGS studies. Third, we provide an overview of important QC metrics, which are applied to WGS data: on the raw data, after mapping and alignment, after variant calling, and after multisample variant calling. Fourth, we illustrate the QC with the data from the GENEtic SequencIng Study Hamburg–Davos (GENESIS‐HD), a study involving more than 9000 human whole genomes. All samples were sequenced on an Illumina NovaSeq 6000 with an average coverage of 35× using a PCR‐free protocol. For QC, one genome in a bottle (GIAB) trio was sequenced in four replicates, and one GIAB sample was successfully sequenced 70 times in different runs. Fifth, we provide empirical data on the compression of raw data using the DRAGEN original read archive (ORA). The most important quality metrics in the application were genetic similarity, sample cross‐contamination, deviations from the expected Het/Hom ratio, relatedness, and coverage. The compression ratio of the raw files using DRAGEN ORA was 5.6:1, and compression time was linear by genome coverage. In summary, the preprocessing, joint calling, and QC of large WGS studies are feasible within a reasonable time, and efficient QC procedures are readily available.

14 June 2023 in Heart
Verified
Journal Article
Open access
PDF file
AZAndreas Ziegler
Andreas Ziegler
AÖAlper Öner
Alper Öner
GQGisela Quadflieg
Gisela Quadflieg
RKRaphael Oliver Koliopanos
Raphael Oliver Koliopanos
ATAlexandre Thiéry
Alexandre Thiéry
CSChristian Schmidt
Christian Schmidt
Objectives The main aim of this work was to analyse the cost-effectiveness of an integrated care concept (NICC) that combines telemonitoring with the support of a care centre in addition to guideline therapy for patients. Secondary aims were to compare health utility and health-related quality of life (QoL) between NICC and standard of care (SoC). Methods The randomised controlled CardioCare MV Trial compared NICC and SoC in patients from Mecklenburg-West Pomerania (Germany) with atrial fibrillation, heart failure or treatment-resistant hypertension. QoL was measured using the EQ-5D-5L at baseline, 6 months and 1 year follow-up. Quality-adjusted life years (QALYs), EQ5D utility scores, Visual Analogue Scale (VAS) Scores and VAS adjusted life years (VAS-AL) were calculated. Cost data were obtained from health insurance companies, and the payer perspective was taken in health economic analyses. Quantile regression was used with adjustments for stratification variables. Results The net benefit of NICC (QALY) was 0.031 (95% CI 0.012 to 0.050; p=0.001) in this trial involving 957 patients. EQ5D Index values, VAS-ALs and VAS were larger for NICC compared with SoC at 1 year follow-up (all p≤0.004). Direct cost per patient and year were €323 (CI €157 to €489) lower in the NICC group. When 2000 patients are served by the care centre, NICC is cost-effective if one is willing to pay €10 652 per QALY per year. Conclusion NICC was associated with higher QoL and health utility. The programme is cost-effective if one is willing to pay approximately €11 000 per QALY per year.

2 May 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
RKRaphael Oliver Koliopanos
Raphael Oliver Koliopanos
FTFelix Thalén
Felix Thalén
SBStefan Blankenberg
Stefan Blankenberg
MZMartin Zoche
Martin Zoche
TZTanja Zeller
Tanja Zeller
AZAndreas Ziegler
Andreas Ziegler
Efficient data compression technologies are crucial to reduce the cost of long-term storage and file transfer in whole genome sequencing studies. This study benchmarked four specialized compression tools developed for paired-end fastq.gz files DRAGEN ORA 4.3.4 (ORA), Genozip 15.0.62, repaq 0.3.0, and SPRING 1.1.1 using three subjects from the genome-in-a-bottle consortium that were sequenced 82 times on an Illumina NovaSeq 6000, with an average coverage of 35x. It additionally compared Genozip with SAMtools 1.20 for the compression of BAM files. All tools provided lossless compression. ORA and Genozip achieved compression ratios of approximately 1:6 when compressing fastq.gz. repaq and SPRING had lower compression ratios of 1:2 and 1:4, respectively. repaq and SPRING took longer for both compression and decompression than ORA and Genozip. Genozip had approximately 16% higher compression for BAM files than SAMtools. However, the BAM compression of SAMtools produces CRAM files, which are compatible with many software packages. ORA, repaq, and SPRING are limited to compressing fastq.gz files, while Genozip supports various file formats. Although Genozip requires an annual license, its source code is freely available, ensuring sustainability. In conclusion, paired-end short-read sequence data can be efficiently compressed using specialized compression software. Commercial tools offer higher compression ratios than freely available software.

4 June 2024 in Biomed
Verified
Journal Article
Open access
PDF file
RKRaphael Oliver Koliopanos
Raphael Oliver Koliopanos
GKGeorgios Koliopanos
Georgios Koliopanos
PGParas Garg
Paras Garg
LGLinlin Guo
Linlin Guo
MRMassimiliano Rossi
Massimiliano Rossi
AZAndreas Ziegler
Andreas Ziegler
Lipoprotein (a) (Lp(a)) is a risk factor for cardiovascular diseases and mainly regulated by the complex LPA gene. We investigated the types of variation in the LPA gene and their predictive performance on Lp(a) concentration. We determined the Kringle IV-type 2 (KIV-2) copy number (CN) using the DRAGEN LPA Caller (DLC) and a read depth-based CN estimator in 8351 short-read whole genome sequencing samples from the GENESIS-HD study. The pentanucleotide repeat in the promoter region was genotyped with GangSTR and ExpansionHunter. Lp(a) concentration was available in 4861 population-based subjects. Predictive performance on Lp(a) concentration was investigated using random forests. The agreement of the KIV-2 CN between the two specialized callers was high (r = 0.9966; 95% confidence interval [CI] 0.9965–0.9968). Allele-specific KIV-2 CN could be determined in 47.0% of the subjects using the DLC. Lp(a) concentration can be better predicted from allele-specific KIV-2 CN than total KIV-2 CN. Two single nucleotide variants, 4925G>A and rs41272114C>T, further improved prediction. The genetically complex LPA gene can be analyzed with excellent agreement between different callers. The allele-specific KIV-2 CN is more important for predicting Lp(a) concentration than the total KIV-2 CN.